We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$253B
AUM Growth
+$4.08B
Cap. Flow
+$937M
Cap. Flow %
0.37%
Top 10 Hldgs %
19.37%
Holding
7,530
New
489
Increased
3,007
Reduced
2,579
Closed
641

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$309M
2
ENB icon
Enbridge
ENB
+$233M
3
T icon
AT&T
T
+$219M
4
AGN
Allergan plc
AGN
+$211M
5
MET icon
MetLife
MET
+$202M

Sector Composition

Rank Sector Weight
1 Financials 21.04%
2 Technology 8.79%
3 Energy 8.22%
4 Industrials 7.49%
5 Communication Services 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIT
6251
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
$2K ﹤0.01%
400
AXAS
6252
DELISTED
Abraxas Petroleum Corp
AXAS
$2K ﹤0.01%
150
-41
-21% -$580
PER
6253
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$2K ﹤0.01%
1,000
-100
-9% -$171
FPAC.U
6254
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
$2K ﹤0.01%
150
+25
+20% +$268
GSB
6255
DELISTED
GlobalSCAPE, Inc.
GSB
$2K ﹤0.01%
+146
New +$1.69K
SMRT
6256
DELISTED
Stein Mart Inc
SMRT
$2K ﹤0.01%
2,607
+907
+53% +$718
ISDS
6257
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic Developed ex-US Small Company
ISDS
$2K ﹤0.01%
100
ALO
6258
DELISTED
Alio Gold Inc
ALO
$2K ﹤0.01%
3,629
+1,513
+72% +$1.15K
SDRL
6259
DELISTED
Seadrill Limited Common Stock
SDRL
$2K ﹤0.01%
742
-605
-45% -$1.92K
CORV
6260
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$2K ﹤0.01%
910
-39
-4% -$79
MDR
6261
CALL
DELISTED
McDermott International
MDR
$2K ﹤0.01%
1,200
+800
+200% +$4.92K
TOO
6262
DELISTED
Teekay Offshore Partners L.P.
TOO
$2K ﹤0.01%
1,850
MLNT
6263
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$2K ﹤0.01%
428
-39,772
-99% -$143K
ARTX
6264
DELISTED
Arotech Corporation
ARTX
$2K ﹤0.01%
612
+605
+8,643% +$1.34K
GTYH
6265
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$2K ﹤0.01%
+345
New +$2.23K
EWEM
6266
DELISTED
Invesco MSCI Emerging Markets Equal Country Weight ETF
EWEM
$2K ﹤0.01%
56
-549
-91% -$16.9K
PACD
6267
DELISTED
Pacific Drilling S.A. Common Shares
PACD
$2K ﹤0.01%
533
-13
-2% -$92
CPAH
6268
DELISTED
Counterpath Corp
CPAH
$2K ﹤0.01%
1,755
+185
+12% +$245
EMKR
6269
DELISTED
Emcore Corp
EMKR
$2K ﹤0.01%
67
-200
-75% -$5.97K
LUNA
6270
DELISTED
Luna Innovations Incorporated
LUNA
$2K ﹤0.01%
+297
New +$1.64K
LLEX
6271
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$2K ﹤0.01%
+6,000
New +$2.31K
GCVRZ
6272
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2K ﹤0.01%
3,699
-75
-2% -$40
ACET icon
6273
Adicet Bio
ACET
$77.3M
$1K ﹤0.01%
+1
New +$1.12K
ACRS icon
6274
Aclaris Therapeutics
ACRS
$863M
$1K ﹤0.01%
645
-3,000
-82% -$4.26K
AEHR icon
6275
Aehr Test Systems
AEHR
$4.02B
$1K ﹤0.01%
+322
New +$461

Similar funds

Royal Bank of Canada's Q3 2019 Portfolio in Review

As of Q3 2019, Royal Bank of Canada held 7,530 positions worth $253B, up 1.6% from $249B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Royal Bank of Canada's Q3 2019 filing shows 489 new, 3,007 increased, 2,579 reduced and 641 closed positions. Its largest new stake was Genmab: 424,217 shares worth $8.6M. The largest sale was iShares Core S&P 500 ETF, an estimated $983M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Energy.

  • Royal Bank of Canada's largest Q3 2019 buy was Genmab: 424,217 shares worth $8.6M.
  • Royal Bank of Canada added most to Boeing in Q3 2019, an estimated $309M increase.
  • Royal Bank of Canada's biggest Q3 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
  • Royal Bank of Canada fully exited Anadarko Petroleum in Q3 2019, selling an estimated $83.7M.
  • Royal Bank of Canada's ten largest holdings make up 19% of its $253B portfolio in Q3 2019.
  • Royal Bank of Canada opened 489 new positions and closed 641 in Q3 2019.
  • Royal Bank of Canada's portfolio value rose 1.6% quarter-over-quarter to $253B.

Based on Royal Bank of Canada's 13F filing for Q3 2019, filed 14 Nov 2019.